Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Agouron to acquire combinatorial chemistry firm Alanex for $62 mil. in stock.

Executive Summary

AGOURON ACQUISITION OF ALANEX VALUES COMBINATORIAL CHEMISTRY FIRM AT ABOUT $62 MIL. based upon Agouron's stock price as of the April 28 signing of a definitive agreement. Agouron will acquire privately-held Alanex for 1 mil. shares of newly-issued stock; Agouron stock closed April 28 at $62 per share. The stock transaction allows Agouron to take advantage of its recent run-up in valuation related to the review and approval of its HIV therapy Viracept ("The Pink Sheet" March 17, T&G-1). The companies expect the transaction to close within 30 days.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts